Finasteride, when given in high oral doses to pregnant monkeys, caused genital abnormalities in male fetuses, but not in female fetuses or those exposed to intravenous finasteride.
Beta-sitosterol may inhibit5-alphareductasetype2 enzyme, potentially reducing DHT levels and promoting hair growth, similar to finasteride but possibly with fewer side effects. Its effectiveness and side effects compared to other treatments like saw palmetto and finasteride remain uncertain due to limited research.
Finasteride and dutasteride are discussed for hair loss, with concerns about their effects on neurosteroids and potential side effects like depression. Alternatives like topical estrogen and lifestyle changes are considered, with varying opinions on mental health and hair regrowth.
The conversation discusses how different factors can stimulate type 1 and type2 isoforms of 5-alphareductase, which are enzymes linked to hair loss. Specific treatments mentioned include oral Dutasteride and topical Finasteride.
GHK-Cu is a potent inhibitor of the type 1 5-alphareductase enzyme in hair follicles, which may reduce hair loss without the side effects associated with type25-alphareductaseinhibitors. The user previously experienced side effects with 5-alphareductaseinhibitors and is considering GHK-Cu as an alternative.
Epristeride is a selective 5alphareductasetype2inhibitor that may reduce scalp DHT similarly to finasteride, with potentially fewer side effects. It is suggested that combining epristeride with finasteride or dutasteride could enhance hair loss treatment effectiveness.